Provided by Tiger Trade Technology Pte. Ltd.

LIFECORE BIOMEDICAL INC

4.40
+0.05001.15%
Post-market: 4.430.0300+0.68%17:59 EDT
Volume:277.40K
Turnover:1.23M
Market Cap:166.55M
PE:-4.75
High:4.60
Open:4.35
Low:4.29
Close:4.35
52wk High:8.98
52wk Low:3.63
Shares:37.85M
Float Shares:19.33M
Volume Ratio:2.11
T/O Rate:1.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9257
EPS(LYR):-0.5400
ROE:-76.41%
ROA:-3.04%
PB:-11.73
PE(LYR):-8.15

Loading ...

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Jul 16

Lifecore Biomedical Is Maintained at Outperform by Barrington Research

Dow Jones
·
Jun 16

Barrington Adjusts Price Target on Lifecore Biomedical to $6.50 From $6, Maintains Outperform Rating

MT Newswires Live
·
Jun 16

Lifecore price target raised to $6.50 from $6 at Barrington

TIPRANKS
·
Jun 16

Lifecore Biomedical Signs Deal to Support Manufacturing of Neurology Injection Product

MT Newswires Live
·
Jun 15

Lifecore Biomedical signs tech transfer, commercial manufacturing deal for marketed neurology injectable suspension

Reuters
·
Jun 15

Lifecore Biomedical Signs New Agreement With Global Pharmaceutical Company

THOMSON REUTERS
·
Jun 15

Lifecore Biomedical Signs New Agreement with Global Pharmaceutical Company

GlobeNewswire
·
Jun 15

Lifecore Biomedical Signs Manufacturing Services Agreement With Ophthalmic Customer

MT Newswires Live
·
Jun 02

Lifecore Biomedical signs manufacturing services deal with new ophthalmic customer

Reuters
·
Jun 02

Lifecore Biomedical Signs Agreement With New Biopharmaceutical Customer

THOMSON REUTERS
·
Jun 02

Lifecore Biomedical attends William Blair Growth Stock Conference

Reuters
·
May 21

Lifecore Biomedical attends CDMO Live Europe, joins tech transfer panel

Reuters
·
May 13

Lifecore reports Q1 EPS (43c), consensus (29c)

TIPRANKS
·
May 07

Lifecore Biomedical Q1 revenue falls 34%, misses analyst estimates

Reuters
·
May 06

BRIEF-Lifecore Biomedical Q1 Revenue USD 23.2 Million

Reuters
·
May 06

Lifecore Biomedical Inc - Reaffirms 2026 Revenue and Adj Ebitda Guidance

THOMSON REUTERS
·
May 06

Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update

GlobeNewswire
·
May 06

Lifecore Biomedical Inc expected to post a loss of 24 cents a share - Earnings Preview

Reuters
·
May 04

Lifecore Biomedical Is Maintained at Outperform by Barrington Research

Dow Jones
·
Apr 30